Status: UPDATED
| Advisory ID: CVE-2026-24217
Key Details
| CVE | CVE-2026-24217 |
| CVSS Score / Version | 8.8 (High) / CVSS v3.1 |
| Updated | 2026-09-24 |
| CVSS Vector | CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H |
| CVSS Prose | attack vector is network; attack complexity is low; privileges required is none; user interaction is required; scope is unchanged; confidentiality impact is high; integrity impact is high; availability impact is high. |
| Affected products | nvidia BioNeMo Framework |
| Classified as | CWE-29 (Path Traversal: '\..\filename') |
| Exploitation prediction (EPSS) | 0.76% probability of exploitation in the next 30 days (54% percentile) -- FIRST.org's EPSS model. |
Affected Products, Subsystems & Sectors
| Subsystems | General OT |
| Sectors | Multiple |
What to Know
NVIDIA BioNeMo Core for Linux contains a vulnerability where a user could cause a path traversal by loading a malicious file. A successful exploit of this vulnerability might lead to code execution, denial of service, information disclosure, and data tampering.
What to Do
Monitor nvidia's web page for any future patch releases. See vendor advisory link below.
References